Hepatitis B hyperimmune (Kedrion)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B hyperimmune (Kedrion)
Drug Alias NameHB IMIG (Kedrion)HB IMIG (hepatitis B virus infection)Human Hepatitis B Immunoglobulins, 180 IU/ml, solution for injectionUman BigImmunohbs
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1979/06/02
Country/TerritoryItaly
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKedrion Spa
China Registration ClassN/A

Develop Information

Active CompaniesKedrion Spa
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A